Evotec SE (ETR:EVT - Get Free Report)'s stock price traded up 8.6% during mid-day trading on Tuesday . The company traded as high as €7.06 ($7.67) and last traded at €7.06 ($7.67). 1,871,717 shares changed hands during trading, an increase of 38% from the average session volume of 1,360,000 shares. The stock had previously closed at €6.50 ($7.07).
Evotec Stock Performance
The stock's 50-day moving average is €6.07 and its 200-day moving average is €8.18. The company has a current ratio of 1.83, a quick ratio of 2.97 and a debt-to-equity ratio of 46.81. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of -7.35, a P/E/G ratio of 0.98 and a beta of 1.05.
Evotec Company Profile
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
